OmniActive Health Technologies on Wednesday announced its acquisition of ENovate Biolife (ENovate), a developer of proprietary, clinically researched botanical ingredients for health solutions. According to the company’s statement, this deal, funded through internal accruals, has further strengthened the Company’s commitment to providing high-quality, scientifically validated health ingredients to consumers globally.
“With advanced encapsulation technologies that enhance ingredient solubility, stability, and bioavailability, TA Associates-backed OmniActive has established itself as a leader in differentiated, safe, and effective dietary supplement solutions. Looking ahead, the Company aims to double its top line, targeting ₹2,000 crores within the next 5 to 6 years from the present ₹1,000 crores. The acquisition is expected to contribute in achieving this growth,” the company said in a statement.
This transaction marks OmniActive’s second strategic expansion, following its purchase of Bangalore-based botanical ingredients company IndFrag in 2017.
“ENovate’s approach to ingredients perfectly aligns with OmniActive’s mission of delivering proven products that make a meaningful difference in consumers’ lives,” said Sanjaya Mariwala, Executive Chairman and Managing Director of OmniActive. “ENovate has done a remarkable job bringing multiple standout ingredients to the market including Muvz, RedNite, and the award-winning Oxyjun. This acquisition is in line with our long-term growth strategy of diversifying product portfolios, accessing new customers and technologies and expanding our presence to new geographies.”
“We are extremely proud of the strides we have made to help our loyal customers deliver products formulated with clinically backed ingredients to address consumer health and performance needs,” said Jayesh Chaudhary, Founder and CEO of ENovate. “OmniActive’s comprehensive capabilities spanning across clinical research, R&D, regulatory, marketing and operations, along with global reach, position us well to elevate these ingredients even further.”
OmniActive’s partnership with ENovate began in 2019 with a U.S. licensing agreement for enXtra, a clinically studied mental energy ingredient. This successful collaboration led to a global expansion, with enXtra now widely commercialised by numerous premium brands worldwide, it added.
